NVO logo

Novo Nordisk A/S (NVO) Retained Earnings

Annual Retained Earnings

$20.15 B
+$4.59 B+29.47%

December 31, 2024

Summary

Performance

1-Year Change

+29.47%

3-Year Change

+83.85%

5-Year Change

+132.5%

15-Year Change

+155.34%

NVO Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.26%
NVO annual retained earnings is higher than 99.26% of companies in Healthcare sector

High & Low

All-time High

$20.15 B
NVO annual retained earnings is currently at an all-time high

3-Year Low

$10.96 B
NVO annual retained earnings is currently +83.85% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVObalance sheetmetrics:

Annual Shareholders Equity

$20.02 B
NVO annual stockholders equity is $20.02 billion

Annual Working Capital

-$7.90 B
NVO annual working capital is -$7.90 billion

Annual Total Assets

$64.99 B
NVO annual total assets is $64.99 billion

Annual Total Liabilities

$44.97 B
NVO annual total liabilities is $44.97 billion

Quarterly Retained Earnings

$20.15 B
+$1.93 B+10.58%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+25.18%

3-Year Change

+83.85%

5-Year Change

+132.5%

NVO Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.42%
NVO quarterly retained earnings is higher than 99.42% of companies in Healthcare sector

High & Low

All-time High

$20.15 B
NVO quarterly retained earnings is currently at an all-time high

3-Year Low

$9.74 B
NVO quarterly retained earnings is currently +106.96% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVObalance sheetmetrics:

Quarterly Shareholders Equity

$20.02 B
NVO quarterly stockholders equity is $20.02 billion

Quarterly Working Capital

-$7.90 B
NVO quarterly working capital is -$7.90 billion

Quarterly Total Assets

$64.99 B
NVO quarterly total assets is $64.99 billion

Quarterly Total Liabilities

$44.97 B
NVO quarterly total liabilities is $44.97 billion

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

Annual Retained Earnings

$20.15 B
NVO annual retained earnings is $20.15 billion

Annual Net Income

$14.65 B
NVO annual net profit is $14.65 billion

Annual Dividends Paid

$6.40 B
NVO annual dividends paid is $6.40 billion

NVO Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.5%+25.2%
3 y3 years+83.8%+83.8%
5 y5 years+132.5%+132.5%

NVO Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+83.8%at high+107.0%
5 y5-yearat high+132.5%at high+148.8%
alltimeall timeat high+9551.4%at high+9551.4%

Novo Nordisk A/S Retained Earnings History

DateAnnualQuarterly
Dec 2024
$20.15 B(+29.5%)
$20.15 B(+10.6%)
Sep 2024
-
$18.22 B(+13.2%)
Jun 2024
-
$16.10 B(+12.4%)
Mar 2024
-
$14.33 B(-8.0%)
Dec 2023
$15.57 B(+34.2%)
$15.57 B(+19.8%)
Sep 2023
-
$12.99 B(+1.0%)
Jun 2023
-
$12.86 B(+14.0%)
Mar 2023
-
$11.28 B(-2.7%)
Dec 2022
$11.60 B(+5.8%)
$11.60 B(+19.1%)
Sep 2022
-
$9.74 B(-5.2%)
Jun 2022
-
$10.27 B(+2.8%)
Mar 2022
-
$10.00 B(-8.8%)
Dec 2021
$10.96 B(+4.0%)
$10.96 B(+3.5%)
Sep 2021
-
$10.60 B(-1.4%)
Jun 2021
-
$10.75 B(+13.1%)
Mar 2021
-
$9.50 B(-9.8%)
Dec 2020
$10.54 B(+21.6%)
$10.54 B(+11.7%)
Sep 2020
-
$9.44 B(+4.2%)
Jun 2020
-
$9.05 B(+11.8%)
Mar 2020
-
$8.10 B(-6.5%)
Dec 2019
$8.67 B(+5.9%)
$8.67 B(+10.1%)
Sep 2019
-
$7.87 B(-3.5%)
Jun 2019
-
$8.16 B(+11.8%)
Mar 2019
-
$7.30 B(-10.8%)
Dec 2018
$8.18 B(+3.7%)
$8.18 B(+7.3%)
Sep 2018
-
$7.62 B(-3.0%)
Jun 2018
-
$7.86 B(+8.9%)
Mar 2018
-
$7.22 B(-8.6%)
Dec 2017
$7.89 B(+20.4%)
$7.89 B(+10.2%)
Sep 2017
-
$7.16 B(-0.9%)
Jun 2017
-
$7.23 B(+23.6%)
Mar 2017
-
$5.85 B(-10.8%)
Dec 2016
$6.56 B(-4.4%)
$6.56 B(+6.1%)
Sep 2016
-
$6.18 B(-2.8%)
Jun 2016
-
$6.36 B(+15.9%)
Mar 2016
-
$5.48 B(-20.0%)
Dec 2015
$6.86 B(+1.8%)
$6.86 B(+6.2%)
Sep 2015
-
$6.46 B(+9.1%)
Jun 2015
-
$5.92 B(+17.3%)
Mar 2015
-
$5.04 B(-25.2%)
Dec 2014
$6.74 B(-11.5%)
$6.74 B(+2.0%)
Sep 2014
-
$6.60 B(-0.0%)
Jun 2014
-
$6.61 B(+10.8%)
Mar 2014
-
$5.96 B(-21.7%)
Dec 2013
$7.61 B(+10.1%)
$7.61 B(+11.3%)
Sep 2013
-
$6.84 B(+14.7%)
Jun 2013
-
$5.96 B(+6.7%)
Mar 2013
-
$5.59 B(-19.2%)
Dec 2012
$6.91 B(+6.9%)
$6.91 B(+15.4%)
Sep 2012
-
$5.99 B(+16.1%)
Jun 2012
-
$5.16 B(-7.8%)
Mar 2012
-
$5.60 B(-13.4%)
DateAnnualQuarterly
Dec 2011
$6.47 B(+0.4%)
$6.47 B(+1.7%)
Sep 2011
-
$6.36 B(-7.5%)
Jun 2011
-
$6.88 B(+9.2%)
Mar 2011
-
$6.30 B(-2.2%)
Dec 2010
$6.44 B(-2.8%)
$6.44 B(+4.6%)
Sep 2010
-
$6.16 B(+13.5%)
Jun 2010
-
$5.43 B(-7.5%)
Mar 2010
-
$5.86 B(-11.5%)
Dec 2009
$6.62 B(+5.3%)
$6.62 B(+0.3%)
Sep 2009
-
$6.60 B(+5.0%)
Jun 2009
-
$6.29 B(+11.6%)
Mar 2009
-
$5.63 B(-10.4%)
Dec 2008
$6.29 B(+4.8%)
$6.29 B(+4.3%)
Sep 2008
-
$6.03 B(-8.4%)
Jun 2008
-
$6.58 B(+5.7%)
Mar 2008
-
$6.23 B(+3.7%)
Dec 2007
$6.00 B(+17.8%)
$6.00 B(-1.1%)
Sep 2007
-
$6.07 B(+3.9%)
Jun 2007
-
$5.84 B(+14.6%)
Mar 2007
-
$5.10 B(-0.0%)
Dec 2006
$5.10 B(+19.3%)
$5.10 B(+11.0%)
Sep 2006
-
$4.59 B(-2.7%)
Jun 2006
-
$4.72 B(+12.0%)
Mar 2006
-
$4.21 B(-1.4%)
Dec 2005
$4.27 B(+2.8%)
$4.27 B(+2.3%)
Sep 2005
-
$4.18 B(+2.7%)
Jun 2005
-
$4.07 B(-5.8%)
Mar 2005
-
$4.32 B(+3.9%)
Dec 2004
$4.16 B(+16.2%)
$4.16 B(+12.3%)
Sep 2004
-
$3.70 B(+4.8%)
Jun 2004
-
$3.53 B(+4.1%)
Mar 2004
-
$3.39 B(-5.2%)
Dec 2003
$3.58 B(+33.2%)
$3.58 B(+33.2%)
Dec 2002
$2.69 B(+38.1%)
$2.69 B(+38.1%)
Dec 2001
$1.95 B(+26.3%)
$1.95 B(+26.3%)
Dec 2000
$1.54 B(-2.4%)
$1.54 B(-2.4%)
Dec 1999
$1.58 B(-30.3%)
$1.58 B(-30.3%)
Dec 1998
$2.26 B(+5.8%)
$2.26 B(+5.8%)
Dec 1997
$2.14 B(+0.9%)
$2.14 B(+0.9%)
Dec 1996
$2.12 B(+6.9%)
$2.12 B(+6.9%)
Dec 1995
$1.98 B(+24.0%)
$1.98 B(+24.0%)
Dec 1994
$1.60 B(+26.8%)
$1.60 B(+26.8%)
Dec 1993
$1.26 B(+10.2%)
$1.26 B(+10.2%)
Dec 1992
$1.15 B(+10.5%)
$1.15 B(+10.5%)
Dec 1991
$1.04 B(+23.9%)
$1.04 B(+23.9%)
Dec 1990
$836.53 M(+36.4%)
$836.53 M(+36.4%)
Dec 1989
$613.38 M(+22.0%)
$613.38 M(+22.0%)
Dec 1988
$502.64 M(-1.5%)
$502.64 M(-1.5%)
Dec 1987
$510.48 M(+30.1%)
$510.48 M(+30.1%)
Dec 1986
$392.49 M(+22.7%)
$392.49 M(+22.7%)
Dec 1985
$319.90 M(+53.2%)
$319.90 M(+53.2%)
Dec 1984
$208.81 M
$208.81 M

FAQ

  • What is Novo Nordisk A/S annual retained earnings?
  • What is the all time high annual retained earnings for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual retained earnings year-on-year change?
  • What is Novo Nordisk A/S quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly retained earnings year-on-year change?

What is Novo Nordisk A/S annual retained earnings?

The current annual retained earnings of NVO is $20.15 B

What is the all time high annual retained earnings for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual retained earnings is $20.15 B

What is Novo Nordisk A/S annual retained earnings year-on-year change?

Over the past year, NVO annual retained earnings has changed by +$4.59 B (+29.47%)

What is Novo Nordisk A/S quarterly retained earnings?

The current quarterly retained earnings of NVO is $20.15 B

What is the all time high quarterly retained earnings for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly retained earnings is $20.15 B

What is Novo Nordisk A/S quarterly retained earnings year-on-year change?

Over the past year, NVO quarterly retained earnings has changed by +$4.05 B (+25.18%)